Episode

FDA Agrees to Review Phentolamine for Presbyopia

Podcast
Eyewire News: The Podcast
Published
Mar 4, 2026
Duration seconds
691
Processing state
not_requested
Canonical source
https://traffic.megaphone.fm/BMCL2873046322.mp3
Audio
https://traffic.megaphone.fm/BMCL2873046322.mp3
JSON
/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/fda-agrees-to-review-phentolamine-for-presbyopia
Markdown
/podcast/eyewire-news-the-podcast-7055536/fda-agrees-to-review-phentolamine-for-presbyopia.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/fda-agrees-to-review-phentolamine-for-presbyopia/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/fda-agrees-to-review-phentolamine-for-presbyopia.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

The FDA agrees to review a presbyopia drop designed to modulate pupil dynamics; a new endocapsular device receives clearance in Europe; and Rayner makes an acquisition to expands its cataract surgery portfolio. Learn more about your ad choices. Visit megaphone.fm/adchoices